Oncology Support
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Access global oncology support market intelligence. Drive strategic BD, investment & regulatory insights for pharma. Stay ahead in cancer care innovation.
Showing 1–2 of 2 articles
Quick answer
NovaPharmaNews Oncology Support hub for NMPA covers 2 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Alphamab Oncology JSKN016 TROP2/HER3 Bispecific ADC Shows Promise for HER2-Negative Breast Cancer at ASCO 2026
Radioligand Therapies for Prostate Cancer: Market Access and Clinical Insights in APAC
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.